MOH closely monitoring COVID-19 amid rising cases in neighbouring countries
KUALA LUMPUR: The Ministry of Health (MOH) is closely monitoring the COVID-19 situation both domestically and abroad, particularly in light of rising cases in neighbouring countries such as Thailand and Singapore.
Minister Datuk Seri Dr Dzulkefly Ahmad said Malaysia remains vigilant despite recording a weekly average of around 600 cases, a figure that is still below the national alert threshold. No COVID-19-related deaths have been reported this year.
'Thailand recorded 16,607 new cases and six deaths between May 4 and May 10, while Singapore reported an estimated 14,200 cases from April 27 to May 3, up from 11,100 the previous week, with 133 hospitalisations,' he said in a post on X today, citing reports from Bangkok Post and The Straits Times.
He said the National Crisis Preparedness and Response Centre (CPRC) has been alerted and is conducting continuous risk assessments to ensure readiness for any developments.
As of May 10, Malaysia had reported a total of 11,727 COVID-19 cases nationwide from Epidemiological Week (EW) 1 to EW19/2025, with the highest figures recorded in the early part of the year, according to the MOH's Disease Control Division.
The peak occurred in EW1 with 960 cases, followed by 1,229 cases each in EW2 and EW3. Since then, numbers have steadily declined, reaching 210 cases in EW15. The average weekly count between EW16 and EW19 remained around 600 cases - still below the alert threshold.
COVID-19 continues to be a notifiable infectious disease under the Prevention and Control of Infectious Diseases Act 1988 [Act 342]. All public and private healthcare facilities are required to report cases in real time via the MOH's e-Notification system, which supports early detection and rapid response to potential outbreaks.
Additionally, the ministry uses a 'rumours surveillance' system to detect unofficial reports from the public, media, and verified sources to strengthen its early warning capabilities.
The public is advised to maintain health precautions, seek treatment promptly if symptomatic, and protect high-risk individuals. Vulnerable groups are also encouraged to receive COVID-19 vaccination to reduce the risk of serious illness or death. Further information is available at www.moh.gov.my.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Borneo Post
3 hours ago
- Borneo Post
SUPP Lambir to host health awareness carnival on June 15
SUPP Lambir organising committee members pose for a photo call, taken after a meeting session prior to the carnival. MIRI (June 7): The Sarawak United People's Party (SUPP) Lambir branch will host a health check awareness carnival on Sunday, June 15, at its premises located at Lot 563, Block 5, Lambir Land District, Jalan Tukau, from 8.30am to 1pm. Deputy Minister of Health Malaysia, Dato Lukanisman Awang Sauni, is expected to officiate the event, which aims to raise public awareness on the importance of regular health screenings and provide health services to residents in Bakam, Tukau, and surrounding areas. The initiative is jointly supported by both private and public agencies, including the National Population and Family Development Board Malaysia (LPPKN) through Klinik Nur Sejahtera, the Ministry of Health's Department of Dentistry, International Optical Co., Best Hearing Aid Centre Miri, and Amcal Pharmacy Sdn Bhd. LPPKN will provide free mammogram screenings and free hysterectomised cancer-specific genotype testing, in addition to basic health tests such as blood glucose, blood pressure, cholesterol, and body mass index (BMI) at RM10; and Pap smear tests at RM45. 'Dental check-ups will be conducted by the Ministry of Health's Department of Dentistry, while International Optical Co. and Best Hearing Aid Centre will offer free visual examinations and hearing tests respectively,' said the organising committee in a statement. Amcal Pharmacy will also conduct free quantum resonance magnetic analytic for interested participants, it added. IN addition to health services, the carnival will feature a children's colouring contest, offering families a fun and educational experience. The contest will be divided into three categories – Kindergartens, Primary 1 to 3, and Primary 4 to 6, with door gifts for all participants. Due to limited participation slots, those interested in registering for the colouring contest are encouraged to contact Lim Lay Cheng on 016-872 5634 or Lee Pei Pei on 012-807 5843. Other attractions include a lucky draw, family photo booth sessions, singing and dancing activities, and public service information booths. These booths will offer details and assistance on programmes such as the Kenyalang Gold Card, Senior Citizen Health Benefits, PeKa B40, and Sarawak Basic Needs Assistance (SKAS). health check awareness carnival Lukanisman Awang Sauni SUPP Lambir
Malaysian Reserve
10 hours ago
- Malaysian Reserve
GSK invests $300,000 to help launch the Pharmacy Innovation in Immunization Research Collaborative (PIIRC) at the University of Waterloo School of Pharmacy
PIIRC serves as a catalyst for innovation by supporting interdisciplinary research and real-world evidence generation focused on improving vaccine access, delivery and education. MISSISSAUGA, ON, June 6, 2025 /CNW/ – GSK is proud to announce a $300,000 investment in the Pharmacy Innovation in Immunization Research Collaborative (PIIRC), a new national initiative led by the School of Pharmacy at the University of Waterloo. This groundbreaking initiative reflects a shared commitment to expanding the role of pharmacy in Canada's immunization landscape and improving equitable access to vaccines across the country. Immunization has never been more critical. The COVID-19 pandemic underscored the life-saving power of vaccines and demonstrated the essential role that pharmacists and pharmacies play in public health. Pharmacy teams have administered more than 20 million COVID-19 vaccines in Canada alone. Yet, there remains untapped potential to leverage the country's 11,000+ pharmacies as accessible, community-based hubs for broader immunization services. PIIRC aims to close that gap. Launched by the largest clinical pharmacy practice research group in Canada, PIIRC serves as a catalyst for innovation by supporting interdisciplinary research and real-world evidence generation focused on improving vaccine access, delivery and education. The initiative brings together researchers from the University of Waterloo, national and international collaborators, policymakers and stakeholders across healthcare and industry to advance pharmacy-based immunization strategies. 'As a global leader in vaccines, we believe in harnessing science and partnerships to tackle the world's most pressing health challenges,' said Michelle Horn, Country Medical Director, GSK Canada. 'Through our founding partnership with PIIRC, we are investing not only in research, but in the future of vaccine delivery in Canada—one that is more accessible, equitable, and community-centred.' Transforming Immunization Through Pharmacy Innovation The objective of PIIRC is to re-imagine the role of pharmacy in immunization—from vaccine administration to health education, monitoring, and system design. Areas of research will include: Expanding the role of pharmacists and pharmacy technicians as vaccine educators, facilitators, and immunizers Overcoming barriers to access, especially among rural residents, older adults, immunocompromised individuals, and other underserved populations Leveraging digital health tools and technology to support clinical decision-making and personalized outreach Countering vaccine misinformation through evidence-based communication strategies and resources for healthcare providers Conducting economic analyses to examine the cost-effectiveness and public health value of pharmacy-based vaccine services Implementing science methodologies to ensure successful and scalable solutions across regions and populations This work will be supported by the School's extensive expertise in pharmacy practice research, health systems design, health economics, public policy, behavioural science, and communication strategies. 'As a leader in clinical pharmacy practice research and community pharmacy innovation, the University of Waterloo's School of Pharmacy continues to push boundaries,' said Andrea Edginton, Hallman Director, School of Pharmacy at the University of Waterloo. 'PIIRC is a natural evolution of our work in immunization, and GSK's partnership will accelerate breakthroughs that improve public health both in Canada and globally.' Impact Beyond the Lab In addition to funding innovative research, GSK's investment will also: Provide funding to support new interdisciplinary projects with direct policy and practice implications Train the next generation of immunization researchers, including PharmD students, graduate students and postdoctoral fellows Facilitate enhanced access to real-world pharmacy data to monitor vaccine uptake and identify areas for intervention Establish a network of community pharmacies engaged in research, data collection and pilot projects Enable regular knowledge translation activities to ensure research is informed by and disseminated to industry, government and community stakeholders Support the creation of an Advisory Board that includes voices from pharmaceutical and insurance companies, regulators, pharmacy associations and the public Strategic Alignment with Public Health and Policy This investment directly supports the Ontario Life Sciences Strategy by demonstrating private sector leadership in supporting community-based immunization services. By investing in evidence that shows how pharmacy can help achieve broader public health goals—including for future vaccine program rollouts such as RSV—GSK is playing a critical role in advancing both healthcare outcomes and policy development. 'Our support for PIIRC is not just about generating data; it's about making a meaningful contribution to the future of healthcare,' added Michelle Horn, Country Medical Director, GSK Canada. 'We're proud to stand alongside the University of Waterloo School of Pharmacy in driving innovative, patient-centred immunization strategies that reflect our mission to get ahead of disease together and our commitment to doing what's right for communities and for public health.' Why Waterloo and Why Now? The University of Waterloo's collaborative ethos, track record of external partnerships and commitment to impact make it an ideal home for PIIRC. The University creates substantial opportunities for high-impact partnerships that bridge the gap between research and application. PIIRC helps shape policy and guides decision-making with timely, actionable evidence that reflects the realities of patients, pharmacists and public health professionals. GSK's early and decisive investment solidifies its reputation as a forward-thinking leader in the pharmacy space and a partner of choice in advancing vaccine innovation. About the University of Waterloo School of PharmacyThe School of Pharmacy at the University of Waterloo is home to Canada's largest clinical pharmacy practice research group and is at the forefront of pharmacy innovation. Through interdisciplinary research and industry collaboration, the School is advancing pharmacy's role in improving health systems and patient outcomes. About GSK GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. Find out more at Cautionary statement regarding forward-looking statements GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described in the 'Risk Factors' section in GSK's Annual Report on Form 20-F for 2024, and GSK's Q1 Results for 2025.
Focus Malaysia
14 hours ago
- Focus Malaysia
Healthy life for a healthy ageing
ETERNITY is what man desires, with or without knowing the purpose of having an eternal life. Albeit, achieving that eternal life remains either in a dream, fiction, or in divine pledge in the life hereafter. Then, a more realistic expectation (goal) for a man is to dream of a prolonged life in this world. According to the World Health Report 1998, the average life expectancy at birth in 2025 was expected to be 73 years, which was 48 years in 1955 and 65 years in 1995. Today, on average, people live more than 73 years. Average life expectancy in Europe, Oceania, America, and Japan is close to 80 years. In Malaysia, it is more than 74 years. Indeed, the prediction came true. In other words, the dream of having a prolonged life is now a reality. How long will people live who will be born in the year 2040 and beyond? The more pressing question is to fathom the expected lifespan of those who are in their 40s or younger today. Looking at the trend of increasing life span, it is not unlikely that they might live longer than those who were in their 40s twenty years ago. Turning the dream of a prolonged life into a reality came with a price—the cost of coping with the ageing population. Developed countries are facing the challenges of declining labor force participation and increased healthcare costs to cope with the aging population. Malaysia will not be an exception. The simple and straightforward policy strategy is to estimate the potential ratio of the aged population, then prepare the necessary infrastructures, including the required number of geriatricians and caregivers to provide support for the elderly. Given the rise of artificial intelligence, the countermeasure to deal with a declining labor force participation and increased healthcare costs might be easier than anticipated. For example, replacing human labour with AI, especially by developed nations would minimise the shortage of human labour in the long run. But that will not solve the problem of the burden of the growing aged population in society. Every nation has to deal with the elderly. At the same time, there is a strong possibility that the elderly in the future might face different health complications from those of today. It is well known that the risk of developing dementia rises steeply with age in people of 60 years. In addition to that, a population-based study in Seoul suggested a potential link between COVID-19 vaccination, particularly mRNA vaccines, and increased incidences of Alzheimer's disease and mild cognitive impairment. If that trend continues, dealing with the cognitively impaired elderly will require additional measures than those with physical ailments. Besides, dealing with the elderly in 2040 and beyond will come with different sets of challenges. Those who are in their 40s today will belong to the elderly by 2040 and beyond. Several unforeseen health determinants emerge among these current youths and adults that were less prevalent among their earlier counterparts. According to the Department of Statistics Malaysia (DOSM) the number of marriages decreased 12.5% from 215,022 (2022) to 188,100 (2023). Arguably, happy marriages are linked to a healthy life at an older age. Besides, a family life comes with an opportunity for family care of the elderly by their next generations. Hence, those are are forced or intended to continue unmarried life might face unforeseen mental and physical health concerns in their old age. Struggles with economic precarity, job security, and workplace stress are more common among the current generations of youths and adults. This array of continuous physical and psychological stress incubates the potential non-communicable diseases, such as cardiovascular diseases, at an older age. In other words, those who are in their 40s living a stressful life are expected to face challenging health issues in their old age. Finally, the experience of COVID-19 has made us ponder with caution if there should be another emerging pandemic that will be equally or more fatal for the elderly with or without the comorbidity of diabetes and cardiovascular diseases. In summary, the elderly in 2040 and beyond might struggle more with cognitive impairment, non-infectious diseases, and above all, psychological distress. Therefore, the long-term policy to ensure good health for the aged population is not only about building infrastructure but also ensuring that the youths and adults today will have a healthy life for a healthy ageing. At the same time, the possibility of unforeseen fatality of the elderly with another potential pandemic must remain in the backdrop of the policy platform. ‒ June 4, 2025 Prof Mohammad is the Deputy Executive Director (Development, Research & Innovation) at International Institute of Public Policy and Management (INPUMA), Universiti Malaya. The views expressed are solely of the author and do not necessarily reflect those of Focus Malaysia. Main image: UNFPA
